Skip to Content

Amrix Approval History

FDA Approved: Yes (First approved February 1, 2007)
Brand name: Amrix
Generic name: cyclobenzaprine
Dosage form: Extended-Release Capsules
Company: ECR Pharmaceuticals
Treatment for: Muscle Spasm

Amrix is an extended-release formulation of the skeletal muscle relaxant cyclobenzaprine, indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.

Development History and FDA Approval Process for Amrix

DateArticle
Feb  1, 2007Approval Amrix Approved - ECR Pharmaceuticals - relief of muscle spasm associated with acute, painful musculoskeletal conditions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide